Tag: mathematics
-
FDA Clears Digital Health Monitoring System
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use.
-
Grant Funds Implanted Brain-Computer Spinal Injury Device
A project to develop a brain-computer device to stimulate upper and lower limb movement in people with spinal cord injuries is receiving a €3.7 million award.
-
Mental Health Therapy, Tech Network Gains Early Funds
A company building a therapy and technology network for improving access to mental health providers is raising $15 million in its first venture round.
-
Biotech, M.D. Anderson Partner on Precision Drug Design
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines.
-
Companies to Partner on Sustainable Synthetic Biochemicals
A producer of plant-based organic acids and a developer of synthetic bio-based materials and services are partnering on new sustainable industrial chemicals.
-
AI-Aided System to Identify Diabetes Complication Risks
Researchers at University of Houston are creating a system aided by algorithms for primary care physicians to better identify people at risk for complications from diabetes.
-
RSV Nose Drops Vaccine Gets FDA Fast Track Tag
A vaccine designed from engineered live viruses and taken as nose drops to prevent respiratory syncytial virus received a Food and Drug Administration fast-track designation.
-
AI Analytics Boost Breast Cancer Assessment Diversity
A genomic analytics company says an ethnicity algorithm added to a personal health questionnaire improves risk assessments for breast cancer across all populations.
-
New Funds Awarded for Rapid Infection Diagnostics
A developer of faster infection diagnostics is receiving another $8.2 million from an international group supporting solutions to antibiotic resistant microbes.
-
“Dark Genome” Drug Discoverer Gains $37M in Early Funds
19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University of Oxford medical school. Nucleome Therapeutics is seeking new treatments for…